Candel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Candel Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $-0.38 | $-0.16 | -137.5 % |
Sep 2023 | 2023-11-09 | $-0.29 | $-0.19 | -52.6 % |
Jun 2023 | 2023-08-10 | $-0.33 | $-0.30 | -10.0 % |
Mar 2023 | 2023-05-11 | $-0.30 | $-0.35 | 14.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-03-28 | $0 | $10.00K | -100.0 % |
Dec 2022 | 2023-03-30 | $31.00K | $20.00K | 55.0 % |
Sep 2022 | 2022-11-10 | $31.00K | $30.00K | 3.33 % |
Dec 2021 | 2022-03-29 | $31.00K | $10.00K | 210.0 % |
Candel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Candel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.33, which missed the estimate of $0.00.
Candel Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.